By 𝔸bdulrazak Tomiwa

Former Pharmaceutical Society of Nigeria, PSN, Ogun State Vice Chairman Olumide Obube has warned that the Iran-U.S. conflict threatens global pharmaceutical supply chains. This instability is expected to drive up medical costs significantly in import-dependent nations like Nigeria.

Nigeria relies heavily on importing essential medicines and raw materials from India and China. These shipments often pass through Middle Eastern hubs, which are currently endangered by military hostilities and transit disruptions.

Rising oil prices and threats to the Strait of Hormuz have already impacted global shipping.

Obube noted that any volatility in these strategic corridors triggers supply chain interruptions that hinder pharmaceutical manufacturing and distribution.

Shortages are already emerging globally, with Nigeria facing severe implications. Local consumers should expect price surges for critical treatments, including antibiotics and medications for hypertension and other chronic conditions.

African nations are especially vulnerable as their primary supply routes traverse these conflict zones. Continued geopolitical instability could eventually lead to shortages of life-saving treatments, such as vaccines and antiretroviral drugs.

Recent market surveys confirm that drug prices have already spiked over the past year. Common medications like insulin and amlodipine, along with medical devices like glucometers, have seen substantial price increases across the country.

To counter these risks, Obube urged the Federal Government to prioritize local drug manufacturing and strategic reserves. Strengthening domestic capacity is essential to reducing Nigeria’s dangerous dependence on volatile global supply chains.